Vireo Growth (VREOF) EBITDA (2020 - 2026)
Vireo Growth's (VREOF) quarterly EBITDA came in at $10.1 million in Q1 2026, up 380.95% year-on-year from $2.1 million in Q1 2025, and up 18.74% quarter-over-quarter from $8.5 million in Q4 2025.
Vireo Growth (VREOF) EBITDA (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed EBITDA across 7 years of filings, most recently posting $10.1 million for Q1 2026.
- EBITDA for Q1 2026 came in at $10.1 million, up 380.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.3 million (up 64.85% YoY), and the FY2025 annual result was $10.3 million, down 25.74% from the prior year.
- EBITDA came in at $10.1 million for Q1 2026 at Vireo Growth, up from $8.5 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $10.1 million in Q1 2026 to a low of -$7.6 million in Q1 2022.
- The 5-year median for EBITDA is $1.4 million (2025), against an average of $2.3 million.
- Peak annual rise in EBITDA reached 28245.85% in 2023, while the deepest fall reached 296.13% in 2023.
- Vireo Growth's EBITDA stood at $867678.0 in 2022, then soared by 530.95% to $5.5 million in 2023, then slumped by 114.09% to -$771619.0 in 2024, then surged by 1202.34% to $8.5 million in 2025, then climbed by 18.74% to $10.1 million in 2026.
- The last three EBITDA figures came in at $10.1 million (Q1 2026), $8.5 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 10.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.10 Mn |
| Dec 31, 2025 | 8.51 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | -1.63 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | -771,619.00 |
| Sep 30, 2024 | 3.93 Mn |
| Jun 30, 2024 | 5.87 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 5.47 Mn |
| Sep 30, 2023 | 5.97 Mn |
| Jun 30, 2023 | -924,363.00 |
| Mar 31, 2023 | 528,017.00 |
| Dec 31, 2022 | 867,678.00 |
| Sep 30, 2022 | -21,216.00 |
| Jun 30, 2022 | 471,312.00 |
| Mar 31, 2022 | -7.60 Mn |
| Dec 31, 2021 | -8.15 Mn |
| Sep 30, 2021 | -4.03 Mn |
| Jun 30, 2021 | -3.00 Mn |